Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people find it straightforward to inject Mounjaro at home. The KwikPen is pre-filled, pre-set and ready to use — there is no drawing up of liquid, no separate needle to attach, and no dose to dial. For the majority of users, the first injection takes under a minute. That said, it is a prescription-only medicine and every course begins with a clinical assessment by a qualified prescriber to confirm it is suitable for you personally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The word "injection" does a lot of unnecessary work. It conjures a glass syringe, a long needle, a clinical setting. Mounjaro's KwikPen is none of those things. It is closer in size and weight to a thick marker pen, and the needle (fully concealed before and after use) is fine-gauge and short, designed specifically for the layer of tissue just beneath the skin surface.
A question our prescribers hear most weeks goes something like: "I'm terrible with needles, is this actually something I can do at home?" The honest answer is that subcutaneous injections of this type require far less technique than the fear around the word "injection" implies. You are not aiming for a vein. You are not estimating a dose. You press the pen against clean skin, hold it there, and press the button. The pen does the rest.
The NHS guidance on tirzepatide confirms the pen is pre-filled and that the Mounjaro injection is given under the skin of the stomach, thigh or upper arm. For specifics on how each step of the process works in practice, the full injection guide walks through each stage in detail.
Anticipation, angle anxiety and skin tension account for most of the difficulty first-time users report. None of them are technical problems.
Anticipation. The moment before pressing the button tends to be the sharpest point of discomfort. Hesitating or tensing the injection site amplifies the sensation. Breathing out slowly and pressing with steady, even pressure rather than jabbing makes a noticeable difference.
Angle anxiety. The KwikPen is designed to sit flat and perpendicular to the skin, not at an angle. Keeping it straight and pressing it firmly enough that the safety cap depresses fully ensures the mechanism fires correctly. Some people hold the pen at a slight unintentional tilt on the first attempt; it usually corrects naturally from the second injection onwards.
Skin tension. If the injection site is relaxed (abdomen especially) a gentle pinch before pressing the pen can help the needle reach the subcutaneous layer cleanly. The choice of injection site can make a real difference here; some people find the thigh or upper arm more comfortable than the abdomen once they have tried all three.
Most users describe the sensation as a brief sharp scratch followed by mild pressure as the liquid is delivered. The whole process is typically over in under ten seconds from pen-to-skin contact.
Once you have pressed the button and held the pen in place for the count recommended in the Patient Information Leaflet, the pen locks automatically, the needle retracts and cannot be re-exposed. There is no recapping required and no risk of an accidental needlestick after that point.
A small amount of redness or a minor bump at the injection site is common and almost always resolves within a few hours. Rotating sites each week (moving around the abdomen, or alternating thighs) keeps any localised skin irritation to a minimum. A detailed look at site rotation is worth reading before your first injection; the guidance at injection site selection covers the anatomy and practical tips.
Used pens are clinical waste. They should be placed in a designated sharps container rather than a household bin or recycling. A one-litre sharps container is sized appropriately for home use and is available from our pharmacy. Your local council or GP surgery will be able to advise on collection.
The broader picture of what the medicine is, how it works and what the titration schedule looks like is covered in the overview of Mounjaro as a treatment.
A small number of people find self-injection consistently distressing rather than just initially unfamiliar. Needle phobia is real and clinically recognised; it is not a reason to dismiss the treatment out of hand, but it is worth discussing openly with your prescriber before starting.
Practically, a few things are well-supported by patient experience. Injecting at room temperature rather than straight from the fridge reduces the stinging sensation that can come from cold liquid entering tissue. Allowing the pen to sit out for around 30 minutes before use is a reasonable approach, but always check the storage guidance in your Patient Information Leaflet for the precise time window, the Mounjaro SmPC, available through the electronic Medicines Compendium, is the definitive reference for storage and handling.
Choosing the same day and time each week also reduces the cognitive load around the injection, it becomes routine quickly. Guidance on timing, including what to do if a dose day falls on a busy travel day, is covered in the section on when to take each weekly dose.
If you are considering Mounjaro and wondering whether the injection aspect would put you off, the most useful step is a conversation rather than a guess. Check your eligibility with our prescribers, there is no obligation, and they can answer questions about technique, timing and what to expect before any treatment begins.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.